|Articles|January 27, 2022
Supplements and Featured Publications
- The Underrecognized Burden of Atopic Dermatitis in the United States
The Underrecognized Burden of Atopic Dermatitis in the United States
Advertisement
This publication is sponsored by AbbVie Inc.
This Clinical Brief provides an overview of the complex pathogenesis, heavy burden, and limited diagnostic, staging, and therapeutic options available for more severe atopic dermatitis.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
3
Clinician Shortages, Access Gaps Challenge Rural Primary Care
4
Epcoritamab With Rituximab Plus Lenalidomide Approved for R/R Follicular Lymphoma in Second Line
5










































